Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)

NCT07640776 is registered in ClinicalTrials.gov with Angiodynamics, Inc. as lead sponsor.

NCT NCT07640776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07640776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)
Lead sponsor
Angiodynamics, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
June 30, 2031
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lower urinary tract symptoms (luts) in men with benign prostatic hyperplasia (bph)